Latanoprost-PPDS

DRUG6 trials

Sponsors

Mati Therapeutics Inc.

Conditions

GlaucomaOcular HypertensionOcular Hypertension (OH)Open Angle Glaucoma

Phase 2

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00650702

Mati Therapeutics Inc.Glaucoma, Ocular Hypertension

Start: 2008-03-31End: 2009-02-28Updated: 2013-09-19

A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

CompletedNCT00820300

Mati Therapeutics Inc.Glaucoma, Ocular Hypertension

Start: 2009-01-31End: 2009-12-31Updated: 2013-09-19

A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

WithdrawnNCT00855517

Mati Therapeutics Inc.Glaucoma, Ocular Hypertension

Start: 2009-03-31End: 2009-07-31Updated: 2013-09-17

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

CompletedNCT01229982

Mati Therapeutics Inc.Ocular Hypertension, Open Angle Glaucoma

Start: 2010-10-31End: 2011-08-31Updated: 2013-09-19

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

CompletedNCT01481077

Mati Therapeutics Inc.Glaucoma, Ocular Hypertension (OH)

Start: 2011-11-30End: 2012-09-30Updated: 2013-09-26

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

CompletedNCT01481051

Mati Therapeutics Inc.Glaucoma, Ocular Hypertension (OH)

Start: 2011-11-30End: 2012-09-30Updated: 2013-09-26